Putnam Investments’s Ascendis Pharma ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
$91.4M Sell
725,651
-46,711
-6% -$5.88M 0.12% 127
2023
Q3
$72.3M Sell
772,362
-127,470
-14% -$11.9M 0.11% 128
2023
Q2
$80.3M Buy
899,832
+158,970
+21% +$14.2M 0.12% 128
2023
Q1
$79.4M Buy
740,862
+34,453
+5% +$3.69M 0.13% 131
2022
Q4
$86.3M Sell
706,409
-81,656
-10% -$9.97M 0.15% 122
2022
Q3
$81.4M Sell
788,065
-15,846
-2% -$1.64M 0.15% 120
2022
Q2
$74.7M Buy
803,911
+171,742
+27% +$16M 0.13% 126
2022
Q1
$74.2M Buy
632,169
+131,054
+26% +$15.4M 0.11% 138
2021
Q4
$67.4M Buy
501,115
+47,154
+10% +$6.34M 0.1% 141
2021
Q3
$72.4M Buy
453,961
+32,488
+8% +$5.18M 0.11% 150
2021
Q2
$55.4M Buy
421,473
+320,657
+318% +$42.2M 0.09% 163
2021
Q1
$13M Sell
100,816
-109,863
-52% -$14.2M 0.02% 330
2020
Q4
$35.1M Sell
210,679
-179,408
-46% -$29.9M 0.06% 190
2020
Q3
$60.2M Sell
390,087
-191,921
-33% -$29.6M 0.12% 149
2020
Q2
$86.1M Buy
582,008
+13,137
+2% +$1.94M 0.18% 112
2020
Q1
$64.1M Buy
568,871
+394,924
+227% +$44.5M 0.17% 125
2019
Q4
$24.2M Buy
173,947
+1,151
+0.7% +$160K 0.05% 240
2019
Q3
$16.6M Sell
172,796
-75,920
-31% -$7.31M 0.04% 282
2019
Q2
$28.6M Buy
248,716
+80,805
+48% +$9.3M 0.06% 214
2019
Q1
$19.8M Buy
167,911
+8,855
+6% +$1.04M 0.05% 246
2018
Q4
$9.97M Sell
159,056
-5,407
-3% -$339K 0.03% 317
2018
Q3
$11.7M Buy
+164,463
New +$11.7M 0.03% 357
2015
Q3
Sell
-18,809
Closed -$331K 1471
2015
Q2
$331K Hold
18,809
﹤0.01% 1406
2015
Q1
$326K Buy
+18,809
New +$326K ﹤0.01% 1390